CIDRAP newsletters options
All patients were hospitalized when the Omicron variant was the most dominant strain in the United States.
Also, the CDC recommends that anyone anticipating sexual activity in the DR Congo and other affected countries receive 2 doses of mpox vaccine.
A conversation with One Health Trust Founder and President Ramanan Laxminarayan.
In 2023, nearly half of all US COVID hospitalizations were among those ages 75 and older.
In other developments, CDC and Ohio partners launched a serosurvey among bovine veterinary workers who attended a recent professional conference.
The source of the girl's infection isn't known, though H9N2 has been reported in the country's poultry before.
California now has the nation's second most dairy farm outbreaks.
In total, 75% of survey respondents strongly or somewhat supported public health wastewater monitoring for infectious diseases.
Researchers say the findings highlight the need for more comprehensive approaches to managing fever in children under 5 in sub-Saharan Africa.
Wastewater levels are still high, but like other markers are showing a downward trend.
The patients weren't connected to each other, but were both exposed to pigs at the same fair.
In other H5N1 developments, the FDA's vaccine advisory group said it will discuss the composition of H5 vaccines when it meets next month.
Through a third-party pharmacy, people interested in the self or caregiver option will complete a screening and eligibility assessment when they order the vaccine.
The number of US measles cases reported this year has risen to 262, up 11 from a week ago.
Vaccine-generated mpox antibodies largely waned after 6 to 12 months.
About 500 people in high risk groups in DRC-border regions have been immunized so far.
The agency is calling for world leaders to take "decisive action" at next week's UN High-Level Meeting on AMR.
All 3 cases are in Baldwin Park, and though the overall risk is low, officials call the development concerning.
Among symptomatic infants, 44% had lower respiratory tract infections.
The new findings come from the ongoing RECOVER trial and build on results seen in a 2023 trial.
